pharma · Acute Ischemic Stroke
Beijing Tiantan Hospital
Beijing Tiantan Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Acute Ischemic Stroke. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s)
Beijing, CN HQ
124 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 124
- Programs
- 1
- Drugs
- 2
- Patents
- 0
rt-PA
Phase 3 · small molecule · Acute Ischemic Stroke
rt-PA for Acute Ischemic Stroke is a Phase 3 program (small_molecule) at Beijing Tiantan Hospital with 1 ClinicalTrials.gov record(s).
Internal code MK02-2020-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Acute Ischemic Stroke
- Status
- completed
- Trials
- 1